Syntekabio

AI-driven drug discovery and development, SaaS platform, supercomputing center

placeSunnyvale, California, United States calendar_todayFounded 2009 groups52 employees language syntekabio.com

Registered entities

Innovation

58 patent families (16 granted) — focus: Physics & computing, Chemistry & metallurgy, Human necessities, Electricity & electronics; filing pace accelerating. Cited 854 times.

YearFilings
20152
20161
20173
20183
20198
20209
20216
20223
20232
202414
202511
20261

Social engagement

Social engagement: 1.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Smile Gate Investment, Korea Development Bank Europe, Altos Ventures Management, Yozma Group Korea; 2 have since exited.

Investor typeCountShare
Venture capital229%
Private equity229%
Other / undisclosed343%

Recent activity

27 Jan 2026
Event
JPM 2026 and Biologics Summit 2026
21 Jan 2026
Event
Biologics Summit
Coming soon